2021
A MULTI-CENTRE AUDIT OF LOWER GASTROINTESTINAL BLEEDING MANAGEMENT (Conference Paper)
Davies, M., Townsend, T., Razanskaite, V., Morgan, J., Baig, D., Fox, J., . . . Smith, P. (2021). A MULTI-CENTRE AUDIT OF LOWER GASTROINTESTINAL BLEEDING MANAGEMENT. In GUT Vol. 70 (pp. A224). doi:10.1136/gutjnl-2020-bsgcampus.428DOI: 10.1136/gutjnl-2020-bsgcampus.428
COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY (Conference Paper)
Townsend, T., Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., . . . Subramanian, S. (2021). COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY. In GUT Vol. 70 (pp. A127). doi:10.1136/gutjnl-2020-bsgcampus.237DOI: 10.1136/gutjnl-2020-bsgcampus.237
2020
Townsend, T., Razanskaite, V., Dodd, S., Storey, D., Michail, S., Morgan, J., . . . Subramanian, S. (2020). Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease. Alimentary Pharmacology and Therapeutics, 52(8), 1341-1352. doi:10.1111/apt.16057DOI: 10.1111/apt.16057
2019
MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE (Conference Paper)
Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., Watters, C., . . . Subramanian, S. (2019). MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE. In GUT Vol. 68 (pp. A100). doi:10.1136/gutjnl-2019-BSGAbstracts.190DOI: 10.1136/gutjnl-2019-BSGAbstracts.190
Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study (Conference Paper)
Townsend, T., Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., . . . Subramanian, S. (2019). Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S407-S408). doi:10.1093/ecco-jcc/jjy222.710DOI: 10.1093/ecco-jcc/jjy222.710
2018
IMMUNE CHECKPOINT INHIBITOR COLITIS- A REVIEW OF CURRENT MANAGEMENT TRENDS (Conference Paper)
Swaminathan, M., Olsson-Brown, A., Subramaniam, S., & Pritchard, M. (2018). IMMUNE CHECKPOINT INHIBITOR COLITIS- A REVIEW OF CURRENT MANAGEMENT TRENDS. In GUT Vol. 67 (pp. A203). doi:10.1136/gutjnl-2018-BSGAbstracts.405DOI: 10.1136/gutjnl-2018-BSGAbstracts.405
Outcomes of single or sequential dual modality loco-regional therapies in Hepatocellular carcinoma (Conference Paper)
Balachandrakumar, V. K., Swaminathan, M., Evans, J., Kibriya, N., Palmer, D., & Cross, T. (2018). Outcomes of single or sequential dual modality loco-regional therapies in Hepatocellular carcinoma. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S206). doi:10.1016/S0168-8278(18)30625-1DOI: 10.1016/S0168-8278(18)30625-1
Swaminathan, M., Ellul, M. A., & Cross, T. J. S. (2018). Hepatic encephalopathy: current challenges and future prospects. HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 10, 1-11. doi:10.2147/HMER.S118964DOI: 10.2147/HMER.S118964
2017
A 6 YEAR SINGLE CENTRE EXPERIENCE OF AUTOMATED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA (Conference Paper)
Cross, T., Ding, W., Swaminathan, M., Farrell, C., Kibriya, N., & Evans, J. (2017). A 6 YEAR SINGLE CENTRE EXPERIENCE OF AUTOMATED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA. In GUT Vol. 66 (pp. A162). doi:10.1136/gutjnl-2017-314472.317DOI: 10.1136/gutjnl-2017-314472.317
OUTCOMES OF SINGLE OR SEQUENTIAL DUAL MODALITY LOCO-REGIONAL THERAPIES IN HEPATOCELLULAR CARCINOMA (Conference Paper)
Cross, T., Swaminathan, M., Kibriya, N., & Evans, J. (2017). OUTCOMES OF SINGLE OR SEQUENTIAL DUAL MODALITY LOCO-REGIONAL THERAPIES IN HEPATOCELLULAR CARCINOMA. In GUT Vol. 66 (pp. A162-A163). doi:10.1136/gutjnl-2017-314472.318DOI: 10.1136/gutjnl-2017-314472.318
A 5-YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS (Conference Paper)
Skouras, T., Bonnet, L., Swaminathan, M., Mcgalliard, R., Metussin, A., Evans, J., . . . Ramesh, J. (2017). A 5-YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS. In GUT Vol. 66 (pp. A40). doi:10.1136/gutjnl-2017-314472.74DOI: 10.1136/gutjnl-2017-314472.74
USE OF THE ENHANCED LIVERPOOL LIVER ABDOMINAL RATIO (ELAAR) TO PREDICT OUTCOME IN PATIENTS ASSESSED FOR TRANSJUGULAR INTRAHEPATIC PORTO-SYSTEMIC SHUNT (TIPS) (Conference Paper)
Swaminathan, M., Smith, L., Kibriya, N., Kumar, P., & Cross, T. (2017). USE OF THE ENHANCED LIVERPOOL LIVER ABDOMINAL RATIO (ELAAR) TO PREDICT OUTCOME IN PATIENTS ASSESSED FOR TRANSJUGULAR INTRAHEPATIC PORTO-SYSTEMIC SHUNT (TIPS). In GUT Vol. 66 (pp. A91-A92). doi:10.1136/gutjnl-2017-314472.177DOI: 10.1136/gutjnl-2017-314472.177
2016
HOW TO USE CROSS-SECTIONAL IMAGING TO ASSESS PROGNOSIS IN END-STAGE CIRRHOSIS WITH THE USE OF ELAAR (THE ENHANCED LIVERPOOL ABDOMINAL AREA RATIO) AND SOFTWARE ASSISTED LIVER VOLUME (Conference Paper)
Smith, L. C., Alam, S., Farrell, C., Swaminathan, M., Chidambaram, V., & Cross, T. (2016). HOW TO USE CROSS-SECTIONAL IMAGING TO ASSESS PROGNOSIS IN END-STAGE CIRRHOSIS WITH THE USE OF ELAAR (THE ENHANCED LIVERPOOL ABDOMINAL AREA RATIO) AND SOFTWARE ASSISTED LIVER VOLUME. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S270). doi:10.1016/S0168-8278(16)00313-5DOI: 10.1016/S0168-8278(16)00313-5
